Seeking Alpha

Alnylam Pharmaceuticals (ALNY -1.7%) and Genzyme, a Sanofi (SNY -0.4%) company, team up to...

Alnylam Pharmaceuticals (ALNY -1.7%) and Genzyme, a Sanofi (SNY -0.4%) company, team up to develop and commercialize RNAi therapeutics targeting transthyretin for the treatment of transthyretin-mediated amyloidosis in Japan and other Asia-Pacific countries.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs